Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 12, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$8.01B
sum of reported positions
Reported positions
489
Changes vs prior quarter
492
132 new · 79 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 155 measured positions in 8 quarters, the typical new or larger position finished −2.9 pts against the S&P 500 and 45% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
| 1.45M | $691M | 8.6% | |
TEVA PHARMACEUTICAL INDS LTD | 12.5M | $412M | 5.1% |
| 1.37M | $397M | 5.0% | |
| 1.1M | $394M | 4.9% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $5.52B | $8.01B |
| Positions | 436 | 489 |
| Biggest line | — | Taiwan Semiconductor Manufacturing 9% |
| 1.95M |
| $391M |
| 4.9% |
| 1.63M | $389M | 4.9% |
| 484K | $367M | 4.6% |
| 3.91M | $345M | 4.3% |
| 1.94M | $228M | 2.8% |
| 590K | $209M | 2.6% |
| 1.17M | $171M | 2.1% |
| 1.8M | $164M | 2.1% |
| 2.24M | $161M | 2.0% |
| 390K | $155M | 1.9% |
| 2.65M | $151M | 1.9% |
| 519K | $146M | 1.8% |
| 757K | $140M | 1.7% |
| 1.63M | $135M | 1.7% |
| 1.34M | $128M | 1.6% |
| 1.41M | $123M | 1.5% |
| 1.14M | $121M | 1.5% |
| 24M | $120M | 1.5% |
| 360K | $118M | 1.5% |
| 667K | $113M | 1.4% |
| 610K | $99.8M | 1.2% |
Booking Holdings (BKNG)
1 → 54 shares (+5300%)
Iren (IREN)
2,450 → 201 shares (−92%)
Jfrog (FROG)
45 → 97 shares (+116%)
Abbott Laboratories (ABT)
95 shares
KEEL INFRASTRUCTURE CORP · CALL
52 shares
Schlumberger (SLB)
180 shares
DoorDash (DASH)
28 → 45 shares (+61%)
FactSet (FDS)
33 → 35 shares (+6%)
Strategy (MSTR)
98 → 90 shares (−8%)
Intuitive Surgical (ISRG)
95K → 19 shares (−100%)
Pfizer (PFE)
311 shares
Danaher Corporation (DHR)
39 shares
Nu Holdings (NU)
500 shares
Stryker Corporation (SYK)
21 shares
eBay Inc. (EBAY)
18K → 59 shares (−100%)
Bristol Myers Squibb (BMY)
112 shares
Equinix (EQIX)
14 → 24 shares (+71%)
Occidental Petroleum (OXY)
1 → 125 shares (+12400%)
Chewy (CHWY)
250 → 296 shares (+18%)
Elastic N.V. (ESTC)
95 → 100 shares (+5%)
Grindr (GRND)
389 shares
Draftkings (DKNG)
369 → 219 shares (−41%)
CarGurus (CARG)
123 → 156 shares (+27%)
Tesla (TSLA) · CALL
18 → 10 shares (−44%)
Envela (ELA)
183 shares
